Visit our Forum platform on https://icpo-forum.org/home.html.

Press Release

2nd ICPO Forum for Theranostics in Precision Oncology to be held as an Hybrid Event, in person at Garching, Munich on October 18th and 19th, 2021

 

Since 2019 the International Centers for Precision Oncology (ICPO) is a German foundation working to enable growing numbers of Cancer Patients worldwide to get access to highly effective diagnostics and treatments in Radiomolecular Precision Oncology. ICPO believes, that scaling patient access globally, can best be achieved through building a global community and international network of Precision Oncology Centers based on shared passion as well as shared knowledge, standards, training and blueprints, thus essentially building a „social franchise model“ for dedicated and optimized Precision Oncology Centers.

 

On October 18th and 19th 2021, the ICPO Foundation will be hosting its 2nd ICPO Forum for Theranostics in the field of Precision Oncology, as a hybrid event, physical in the heart of the Science Campus in Garching Munich right by one of the few reactors producing medical isotopes worldwide. Despite Covid restrictions over 200 participants will attend from India, China, Middle-East, Africa, the US, Canada and many more locations around the globe, while more than 15 industry sponsors are kindly supporting the event. The ICPO Forum streaming platform will allow for multidisciplinary interaction between physical and virtual participants across all horizons such as industry, academia, societies, associations, foundations, investors and philanthropists.

 

By attending the ICPO Forum one recognizes the Paradigm Shift to Precision Oncology and lives up to its promises: from late to early diagnosis, from helpless to involved patients, from „trial and error“ to predictable outcomes, from severe to low or no side-effects, from exploding costs to sustainable health economics, from months to years of survival with preserved quality of life.
Ultimately the ICPO next generation “social franchise model” has the power to accelerate the paradigm shift in Oncology by implementing a more effective patient centered focus around new theranostics technologies, this to all patients in need irrespectively of race, countries, social status and all else.

 

The program of the 2nd ICPO Forum has been designed to encompass different viewpoints in order to understand and shape the future growth of theranostics together. After an official address by the Technical University München, the patient voice will be heard highlighting patient benefits of Precision Oncology, followed by a keynote lecture by Professor Dr. Richard P. Baum (Curanosticum Wiesbaden-Frankfurt, Germany). The following sessions will be articulated around industry technology advances and supply chains scale up of radiopharmaceuticals and complemented by a multidisciplinary panel discussion. Eventually, the ICPO Foundation will present an overview of its major initiatives, namely the ICPO Academy and the ICPO Centers Network.

 

With its 2nd Forum edition, the ICPO stands more than ever for its mission to support the community, science, training, and expansion of patient access worldwide in Precision Oncology in an inclusive and collaborative approach!

 

All valuable information to make a donation or become a friend, supporter or partner of the ICPO Foundation can be found on the website www.icpo.foundation.

For more information, please contact:
Katja Schorn
Phone +49 (0)611 - 341 863 0
E-Mail katja.schorn@icpo.foundation

You can download this press release here.